.Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AX03_ZincCompounds.ZincCompounds .Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AX03_ZincCompounds.ZincCompounds| name: | ZincCompounds |
| ATC code: | S01AX03 | route: | ophthalmic |
| n-compartments | 1 |
Zinc compounds (ATC code S01AX03) are typically used in ophthalmic preparations for the local treatment of eye irritation and inflammation. They are not systemically absorbed to a significant extent and are not typically used systemically. Zinc plays a role in various enzymatic reactions and cell membrane stabilization. The ophthalmic use of zinc compounds has decreased with the availability of more effective agents.
No pharmacokinetic (PK) data are published for ophthalmically administered zinc compounds in humans due to low systemic absorption; parameters below are estimated based on general zinc systemic exposure.